New Delhi is set to host the 12th edition of iPHEX, an international exhibition focused on the pharmaceutical and healthcare industry, from September 7 to 9, 2026, at Bharat Mandapam. The three-day event is being organised by the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) with the support of the Ministry of Commerce and Industry, Government of India.
The exhibition is expected to provide a platform for Indian pharmaceutical companies to engage with international buyers, regulators, procurement agencies and other healthcare industry stakeholders. According to PHARMEXCIL, iPHEX has developed into a global platform connecting Indian pharmaceutical exporters with international markets and industry participants.
iPHEX 2026 Dates and Venue
The 12th International Exhibition on Pharmaceuticals and Healthcare Industry will be held from September 7 to 9 at Bharat Mandapam in New Delhi. PHARMEXCIL has stated that the 2026 edition will cover Exhibition Halls 1, 2, 3, 4, 5 and 5FF.
The event will take place as part of the broader Bharat Health Global Expo 2026 programme. PHARMEXCIL has also announced that the inaugural ceremony for the expo and iPHEX 2026 is scheduled for September 6 at Bharat Mandapam.
Focus on Pharmaceutical Exports
A key focus of iPHEX 2026 is to strengthen connections between Indian pharmaceutical exporters and overseas markets. The exhibition is designed to bring companies and international business stakeholders together, creating opportunities for discussions around pharmaceutical products, market access and industry cooperation.
The event comes as Indian pharmaceutical companies continue to expand their presence across international markets, making buyer and regulatory engagement an important part of the export ecosystem.
Global Industry Participation
PHARMEXCIL has positioned iPHEX as a platform for interaction between Indian exporters and international buyers, regulators and procurement agencies. Such participation can provide companies with opportunities to explore new business relationships and understand requirements in overseas markets.
The exhibition is also expected to facilitate interaction among other stakeholders across the pharmaceutical and healthcare sectors.
Conference on Global Market Access
Alongside the exhibition, PHARMEXCIL has announced a conference on “Navigating Global Pharmaceutical Market Access in a Changing World: Trade, Regulatory Reform and Export Promotion” for September 8 at Bharat Mandapam.
The conference is expected to place attention on issues affecting pharmaceutical companies seeking access to international markets, including trade and regulatory developments.
Government-Backed Industry Platform
PHARMEXCIL, the Pharmaceuticals Export Promotion Council of India, is organising the event with support from the Ministry of Commerce and Industry. The council has been coordinating exhibitor participation and other preparations for the 2026 edition through a series of official circulars.
With iPHEX 2026 bringing together pharmaceutical and healthcare companies and international stakeholders in New Delhi, the exhibition is set to serve as an important industry platform for business engagement, export promotion and discussions around global pharmaceutical markets.
.jpg)
